Abstract
New Acalabrutinib Formulation Enables Co-Administration with Proton Pump Inhibitors and Dosing in Patients Unable to Swallow Capsules (ELEVATE-PLUS)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have